Product NDC: | 0591-0606 |
Proprietary Name: | Labetalol hydrochloride |
Non Proprietary Name: | Labetalol hydrochloride |
Active Ingredient(s): | 200 mg/1 & nbsp; Labetalol hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-0606 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075133 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980803 |
Package NDC: | 0591-0606-10 |
Package Description: | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0606-10) |
NDC Code | 0591-0606-10 |
Proprietary Name | Labetalol hydrochloride |
Package Description | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0606-10) |
Product NDC | 0591-0606 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Labetalol hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19980803 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | LABETALOL HYDROCHLORIDE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |